BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:CASI Pharmaceuticals\, Inc. (CASIF) investor events
X-WR-CALNAME:CASI Pharmaceuticals\, Inc. (CASIF) investor events
DESCRIPTION:Earnings calls and investor events for CASI Pharmaceuticals\, I
 nc. (CASIF)\, from Equibles.
X-WR-CALDESC:Earnings calls and investor events for CASI Pharmaceuticals\, 
 Inc. (CASIF)\, from Equibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:8f47ec3e-4523-4024-a543-5259c30af43b@equibles.com
DTSTAMP:20260624T233123Z
DTSTART;VALUE=DATE:20251207
DTEND;VALUE=DATE:20251208
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:CASI Pharmaceuticals\, Inc. (CASIF) Annual General Meeting: CASI Ph
 armaceuticals Presents Clinical Results for CID-103 at the 67th American S
 ociety of Hematology (ASH) Annual Meeting in Orlando\, Florida
DESCRIPTION:CASI Pharmaceuticals Presents Clinical Results for CID-103 at t
 he 67th American Society of Hematology (ASH) Annual Meeting in Orlando\, F
 lorida\nThe start time has not been announced.\nWebcast: https://irp.cdn-w
 ebsite.com/b245f48c/files/uploaded/ASH+2025+ITP+Poster-2025.12.01.pdf
END:VEVENT
END:VCALENDAR